News

The patent is important to the company’s optical biopsy technology because it provides protection in the areas of tissue surveillance, characterization, diagnosis and treatment. It is said to

Greg Brown, CEO of ImpediMed, said: “Metagenics has been an outstanding Australian partner using ImpediMed’s body composition analysis devices for several years. This expanded relationship makes sense in

Omnilab’s core business of supplying instrumentation, consumables and services is expected to complement VWR’s local expertise in chemicals, consumables and life science products. Manuel Brocke-Benz, senior vice president

The payment was triggered by the market launch of Rotarix in the US. Rotarix is marketed worldwide by GlaxoSmithKline. John Leone, a partner at Paul Capital Healthcare, said:

Under the terms of the agreement, Roche’s exclusive rights to sell and distribute the ProbeLibrary products are extended on a co-exclusive basis. In addition, Roche obtains co-exclusive rights

This compound originates from the work of Pharmaleads’s chief scientists, Bernard Roques and Marie-Claude Fournie-Zaluski, and is a dual inhibitor of both enzymes responsible for the rapid degradation

Transave has previously reported positive Phase II data on Arikace from a randomized, placebo-controlled, 15-center study conducted in Europe. The study demonstrated that Arikace, delivered once daily for

Elevess is an injectable filler that reduces the appearance of lines and wrinkles on the face, and was the first hyaluronic acid-based dermal filler approved by the FDA

In this role, Mr Perley will be responsible for continuing the supervision of the project to build the Devens facility and will have overall management responsibility for the